Clinical Trials Directory

Trials / Completed

CompletedNCT03335085

Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences

Long-term Consequences of Childhood Adversity: Exploring Stress Responsive Molecular Pathways and Psychobiological Intervention Models

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Ruhr University of Bochum · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study evaluates whether intranasal administration of a single dose of oxytocin improves the ability to recognize emotional states. In a cross-over design, half of the participants first received oxytocin, the other half first received placebo.

Detailed description

Adverse childhood experience such as neglect or abuse can lead to long-term deficits in emotion processing abilities, and these effects might be mediated via alterations in oxytocin production or sensitivity. The goal of this study was to test whether emotion recognition abilities and empathy might be improved by intranasal oxytocin administration in adults with a history of childhood maltreatment. In a double-blind, placebo-controlled experiment with a crossover design, we assessed the performance of 40 healthy participants with a history of childhood adversity on the Reading the Mind in the Eyes Test (RMET) and an emotion recognition task under 24 IU oxytocin vs. placebo and compared them to a control group of 40 matched individuals without traumatic childhood experiences.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin
OTHERPlacebo

Timeline

Start date
2011-07-01
Primary completion
2013-03-23
Completion
2013-11-05
First posted
2017-11-07
Last updated
2017-11-07

Source: ClinicalTrials.gov record NCT03335085. Inclusion in this directory is not an endorsement.